Funded Early Detection and Screening Grants

Active/Completed

Topics

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Herman, James G.	University Of Pittsburgh At Pittsburgh United States	Optimizing Ultrasensitive DNA methylation detection for lung cancer and other malignancies	5U2CCA271885-03	Wendy Wang, Ph.D., M.Sc.
Hirsch, Fred R	Icahn School Of Medicine At Mount Sinai United States	Vulnerability of SARS- CoV-2 Infection in Lung Cancer Based on Serological Antibody Analyses	3U54CA260560-02S3	Guillermo Marquez, Ph.D.
Hitchins, Megan P	Cedars-Sinai Medical Center United States	Discovery and verification of methylated circulating tumor DNA markers for the detection of colorectal cancer in subjects under 50 years of age	5R01CA252042-04	Matthew Young, Ph.D.
Hollingsworth, Michael A.	University Of Nebraska Medical Center United States	Pancreatic Cancer Detection Consortium	5U01CA210240-08	Matthew Young, Ph.D.
Hoshida, Yujin	Ut Southwestern Medical Center United States	Therapeutic modulation of a proteomic HCC risk signature with statins in patients with liver cirrhosis	5U01CA288375-02	Matthew Young, Ph.D.
Houghton, A Mcgarry	Fred Hutchinson Cancer Center United States	Tumor-specific autoantibodies for SCLC early detection	5R01CA243328-06	Guillermo Marquez, Ph.D.
Hsu, Li	Fred Hutchinson Cancer Center United States	Statistical Methods for Precision Prevention	1R01CA297681-01	Claire Zhu, Ph.D.
Huang, Yijian	Emory University United States	Analytic diagnosis methods for disease ruling	1R01CA283687-01A1	Guillermo Marquez, Ph.D.
Huang, Ying	Fred Hutchinson Cancer Center United States	Accelerating biomarker development through novel statistical methods for analyzing phase III/IV studies	5R01CA277133-03	Matthew Young, Ph.D.
Hur, Chin	Columbia University Health Sciences United States	Optimal Colorectal Cancer Surveillance Strategy for Lynch Syndrome by Genotype	3R01CA257333-04S1	Matthew Young, Ph.D.
Ibsen, Stuart Duncan	Oregon Health & Science University United States	Distinguishing Pancreatic Cancer from Benign Pancreatic Disease using Nanoparticle-based Biomarkers	5R37CA258787-04	Matthew Young, Ph.D.
Iwelunmor, Juliet	Washington University United States	Innovative Rapid Enabling, Affordable, point-of-Care HPV Self-Testing Strategy (I-REACH)	5U01CA279863-03	Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
James, Aimee S	Washington University United States	Administrative Supplement to Building equity in cancer screening through research: The Siteman Catchment CSRN Hub	3UG1CA286946-02S1	Elyse LeeVan, M.D., M.P.H.
Ji, Hanlee P	Stanford University United States	Single-molecule nanopore-based identification of methylome signatures in cfDNA for early colorectal cancer detection	1U01CA282212-01A1	Claire Zhu, Ph.D.
Justilien, Verline	Mayo Clinic Jacksonville United States	ECT2 Isoform Switch in Pancreatic Cancer.	1R21CA296671-01	Matthew Young, Ph.D.